You Sylvaine, Chatenoud Lucienne
Université René Descartes Paris 5, INSERM U580, Hôpital Necker-Enfants Malades, Paris, France.
J Clin Invest. 2006 Dec;116(12):3108-10. doi: 10.1172/JCI30760.
In healthy individuals the immune system does not react aggressively toward host cells, a phenomenon defined as self tolerance. If self tolerance is broken autoimmune disease can develop, during which autoreactive lymphocytes are directed to a variety of autoantigenic epitopes. However, researchers have yet to determine whether immune responses to multiple autoantigens develop independently of each other or are the result of the response "spreading" from one autoantigen to another. In a study of NOD mice in this issue of the JCI, Krishnamurthy et al. show that the autoreactive T cell response to the autoantigen proinsulin lies upstream of that to islet-specific glucose-6-phosphatase catalytic subunit-related protein, suggesting that the pathogenic autoimmune response to proinsulin subsequently spreads to other antigens (see the related article beginning on page 3258). These data support the current view that this pancreatic beta cell hormone is the first autoantigen targeted by the immune response in autoimmune diabetes.
在健康个体中,免疫系统不会对宿主细胞产生强烈反应,这一现象被定义为自身耐受。如果自身耐受被打破,就可能会发展出自身免疫性疾病,在此期间,自身反应性淋巴细胞会针对多种自身抗原表位。然而,研究人员尚未确定对多种自身抗原的免疫反应是相互独立发展的,还是从一种自身抗原“扩散”到另一种自身抗原的反应结果。在本期《临床研究杂志》对非肥胖糖尿病(NOD)小鼠的一项研究中,克里希纳穆尔蒂等人表明,对自身抗原胰岛素原的自身反应性T细胞反应位于对胰岛特异性葡萄糖-6-磷酸酶催化亚基相关蛋白的反应上游,这表明对胰岛素原的致病性自身免疫反应随后会扩散到其他抗原(见第3258页开始的相关文章)。这些数据支持了当前的观点,即这种胰腺β细胞激素是自身免疫性糖尿病中免疫反应靶向的首个自身抗原。